Focus On

Smart & Biggar adds three partners, promotes counsel

Tuesday, January 07, 2020 @ 8:53 AM | By John Chunn


Smart & Biggar LLP and Smart & Biggar IP Agency Co. announced that Graham Hood, Lei Liu and Patrick Roszell have been admitted to the partnership. In addition, Lynn Ing has been promoted to counsel.

According to the firms’ press release, Hood is a trademark lawyer and litigator. He regularly advises clients on effective strategies to manage and monetize trademark portfolios and has successfully enforced clients’ trademark rights in Canada’s federal and provincial courts. He is also experienced in protecting brand owners’ rights at the border and online, and preventing the importation, distribution and sale of counterfeit goods and pirated works.

Roszell is a lawyer and patent agent with close to a decade of experience counselling clients on the creation, protection and management of intellectual property (IP) rights. He focuses on patent prosecution and IP strategy, including drafting and prosecuting patent applications, providing patentability, infringement and freedom to operate opinions and advising on IP-related agreements. His expertise includes computer hardware and software, telecommunications, power generation, oil and gas, manufacturing and medical devices.

Liu is a patent agent with a PhD and a background in biotechnology, biological science and chemistry. He drafts and prosecutes Canadian patent applications and designs and implements IP strategies that align with clients’ business interests, and he also assists clients in IP transactions, providing counsel on IP due diligence, IP audits and IP-related agreements. He counts among his clients pharmaceutical and biotechnology companies, green technology companies, research institutions and universities.

Ing has more than a decade of experience in patent prosecution and litigation, bolstered by her scientific expertise and background in cancer research. Among her many accomplishments, Ing held an integral role in the successful appeal to the Supreme Court of Canada in AstraZeneca v. Apotex 2017 SCC 36, leading to the abolishment of the “promise doctrine” of patent utility in Canada. Ing advises clients on biotechnology, chemical and pharmaceutical patent applications including for biologics, and represents them in patent infringement, impeachment and damages actions and litigation under the Patented Medicines (Notice of Compliance) Regulations.

Daphne Lainson, chair of the partnership, said: “We are proud to welcome Graham, Lei and Patrick to the partnership and to recognize Lynn’s achievements with a promotion to counsel. Their deep understanding of the law and our clients’ business, together with proven results strengthen and entrench our position as the leading firm in Canada for intellectual property and related specialty areas of law.”